Elanco price target lowered to $13 from $14 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Elanco (ELAN) to $13 from $14 and keeps an Equal Weight rating on the shares. Q4 EPS of 14c ...
1ELAN : Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time...
Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge.
Pharmabiz16h
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...
Elanco price target lowered to $19 from $20 at Barclays
Barclays lowered the firm’s price target on Elanco (ELAN) to $19 from $20 and keeps an Overweight rating on the shares. The firm sees a “solid ...
Elanco Animal Health to Commercialize Vaccine for Dairy Cattle to Battle Bird Flu Outbreak
Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.
Elanco slips as forex headwinds weigh on outlook
Elanco Animal Health (NYSE:ELAN) traded lower in the premarket on Tuesday after the veterinary product maker, with its Q4 2024 results, set its full-year outlook below consensus, citing an unfavorable ...
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Myriad Genetics (MYGN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elanco Animal Health (ELAN – Research Report) and Myriad ...
Elanco Animal Health 4Q Loss Narrows, Sales Decline
Elanco Animal Health narrowed its fourth-quarter loss despite lower sales, but its forecast for the current quarter and full year came in below Wall Street's estimates.